Robert Brown

Whole–genome characterization of chemoresistant ovarian cancer

Ann‐Marie Patch, Elizabeth L. Christie, Dariush Etemadmoghadam et al. · Nature · 2015 · 1.6K citations

Medicine, Genetics, Oncology +14

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Richard W. Tothill, Anna V. Tinker, Joshy George et al. · Clinical Cancer Research · 2008 · 1.5K citations

Medicine, Gynecology, Oncology +17

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt, Holly Tovey, Maggie C.U. Cheang et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Oncology, Pharmacology +11

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen, Karen A. Pooley, Sharon E. Johnatty et al. · Nature Genetics · 2013 · 540 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.

Jane A. Plumb, Gordon Strathdee, Julieann Sludden et al. · PubMed · 2000 · 488 citations

Medicine, Cancer Biology, Oncology +16